News
Roche offers $15bn for strategic-level deal with Hansoh
A year after signing a first deal with Hansoh worth up to $1.45 billion, Roche has returned for another that could be more than 10 times larger.
News
Merck buys Silence and its siRNA pipeline for $1.3bn
Merck KGaA has reached a deal to acquire UK-based Silence Therapeutics in a $1.3bn deal that would give it a late-stage drug for polycythemia vera.
R&D
Changing Faces: Board of Director and Advisory Board hires, ...
September’s boardroom moves brought seasoned pharma executives, investors, and scientific leaders into new governance and advisory roles across the life sciences sector.
News
UK Biobank partners with industry on 'most detailed' immune ...
The UK Biobank has teamed up with industry partners to create "the world’s most detailed, large-scale picture of the human immune system."
News
Data reveal is promising for GSK's lung cancer drug ris-rez
The first data from GSK's international trial of B7-H3-targeted ADC ris-rez in small cell lung cancer back up earlier results from a Chinese study.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
